Christoph Brönnimann
Chief Executive Officer en MEDARTIS HOLDING AG .
Fortuna: 3 M $ al 31/03/2024
Perfil
Christoph Brönnimann is currently the Chief Executive Officer at Medartis Holding AG and Medartis AG.
He is also a Director at Johnson & Johnson Foundation Scotland and Keri Medical SA. In the past, he worked as a Product Manager at Roche Vitamins, Inc. from 1995 to 2000 and as the General Manager-Switzerland at DePuy Synthes, Inc. from 2005 to 2012.
Dr. Brönnimann holds a doctorate degree from the Swiss Federal Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDARTIS HOLDING AG
0.26% | 31/12/2022 | 31 847 ( 0.26% ) | 3 M $ | 31/03/2024 |
Cargos activos de Christoph Brönnimann
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDARTIS HOLDING AG | Chief Executive Officer | 01/09/2019 |
Johnson & Johnson Foundation Scotland
 Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Director/Board Member | - |
| Medartis AG | Chief Executive Officer | 01/09/2019 |
Keri Medical SA
 Keri Medical SA Medical SpecialtiesHealth Technology Keri Medical SA engages in the development and manufacture of implants for hand and wrist surgery. It trademarks include KeriFix, KeriLock, Motec, Reaxon, and Touch. The company was founded by Bernard Prandi and Dougal Bendjaballah in 2016 and is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Antiguos cargos conocidos de Christoph Brönnimann.
| Empresas | Cargo | Fin |
|---|---|---|
DePuy Synthes, Inc.
 DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Corporate Officer/Principal | 01/08/2012 |
Roche Vitamins, Inc.
 Roche Vitamins, Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Vitamins, Inc. is an American company. | Corporate Officer/Principal | 01/01/2000 |
Formación de Christoph Brönnimann.
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEDARTIS HOLDING AG | Health Technology |
| Empresas privadas | 5 |
|---|---|
Roche Vitamins, Inc.
Roche Vitamins, Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Vitamins, Inc. is an American company. | Health Technology |
DePuy Synthes, Inc.
DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Health Technology |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
Keri Medical SA
Keri Medical SA Medical SpecialtiesHealth Technology Keri Medical SA engages in the development and manufacture of implants for hand and wrist surgery. It trademarks include KeriFix, KeriLock, Motec, Reaxon, and Touch. The company was founded by Bernard Prandi and Dougal Bendjaballah in 2016 and is headquartered in Geneva, Switzerland. | Health Technology |
| Medartis AG |
- Bolsa de valores
- Insiders
- Christoph Brönnimann
